METHOD FOR TREATING IFN-ALPHA RELATED CONDITIONS

作者: Grouard-Vogel Géraldine , Vandepapelière Pierre , Fanget Bernard , Roucairol Camille , Dhellin Olivier

DOI:

关键词:

摘要: The present invention relates to an immunogenic product comprising IFN± coupled a carrier protein molecule that is capable induce in vivo anti-IFN± antibodies and its use for treating related conditions.

参考文章(5)
Mary K. Crow, Interferon-alpha: A Therapeutic Target in Systemic Lupus Erythematosus Rheumatic Diseases Clinics of North America. ,vol. 36, pp. 173- 186 ,(2010) , 10.1016/J.RDC.2009.12.008
Yihong Yao, Laura Richman, Brandon W. Higgs, Christopher A. Morehouse, Melissa de los Reyes, Philip Brohawn, Jianliang Zhang, Barbara White, Anthony J. Coyle, Peter A. Kiener, Bahija Jallal, Neutralization of interferon‐α/β–inducible genes and downstream effect in a phase I trial of an anti–interferon‐α monoclonal antibody in systemic lupus erythematosus Arthritis & Rheumatism. ,vol. 60, pp. 1785- 1796 ,(2009) , 10.1002/ART.24557
Mary K Crow, Type I interferon in organ-targeted autoimmune and inflammatory diseases Arthritis Research & Therapy. ,vol. 12, pp. S5- 10 ,(2010) , 10.1186/AR2886
Alexis Mathian, Zahir Amoura, Estelle Adam, Fabien Colaone, Marco F M Hoekman, Olivier Dhellin, Pierre Vandepapelière, Julien Haroche, Jean-Charles Piette, Pierre Lebon, Géraldine Grouard-Vogel, Active immunisation of human interferon α transgenic mice with a human interferon α Kinoid induces antibodies that neutralise interferon α in sera from patients with systemic lupus erythematosus Annals of the Rheumatic Diseases. ,vol. 70, pp. 1138- 1143 ,(2011) , 10.1136/ARD.2010.141101